201 related articles for article (PubMed ID: 27889632)
1. Synthesis, biological evaluation and in silico molecular modeling of pyrrolyl benzohydrazide derivatives as enoyl ACP reductase inhibitors.
Joshi SD; Dixit SR; Kulkarni VH; Lherbet C; Nadagouda MN; Aminabhavi TM
Eur J Med Chem; 2017 Jan; 126():286-297. PubMed ID: 27889632
[TBL] [Abstract][Full Text] [Related]
2. Discovery of target based novel pyrrolyl phenoxy derivatives as antimycobacterial agents: an in silico approach.
More UA; Joshi SD; Aminabhavi TM; Kulkarni VH; Badiger AM; Lherbet C
Eur J Med Chem; 2015 Apr; 94():317-39. PubMed ID: 25771110
[TBL] [Abstract][Full Text] [Related]
3. Chemical synthesis and in silico molecular modeling of novel pyrrolyl benzohydrazide derivatives: Their biological evaluation against enoyl ACP reductase (InhA) and Mycobacterium tuberculosis.
Joshi SD; More UA; Dixit SR; Balmi SV; Kulkarni BG; Ullagaddi G; Lherbet C; Aminabhavi TM
Bioorg Chem; 2017 Dec; 75():181-200. PubMed ID: 28961440
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties.
Joshi SD; Dixit SR; Kirankumar MN; Aminabhavi TM; Raju KV; Narayan R; Lherbet C; Yang KS
Eur J Med Chem; 2016 Jan; 107():133-52. PubMed ID: 26580979
[TBL] [Abstract][Full Text] [Related]
5. Pharmacophore mapping, molecular docking, chemical synthesis of some novel pyrrolyl benzamide derivatives and evaluation of their inhibitory activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
Joshi SD; Dixit SR; Basha J; Kulkarni VH; Aminabhavi TM; Nadagouda MN; Lherbet C
Bioorg Chem; 2018 Dec; 81():440-453. PubMed ID: 30223149
[TBL] [Abstract][Full Text] [Related]
6. Pyrrolyl Pyrazoline Carbaldehydes as Enoyl-ACP Reductase Inhibitors: Design, Synthesis and Antitubercular Activity.
Dixit SR; Joshi SD; Kulkarni VH; Jalalpure SS; Kumbar VM; Mudaraddi TY; Nadagouda MN; Aminabhavi TM
Open Med Chem J; 2017; 11():92-108. PubMed ID: 29151986
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, molecular docking study and biological evaluation of new pyrrole scaffolds as potential antitubercular agents for dual targeting of enoyl ACP reductase and dihydrofolate reductase.
Mahnashi MH; Avunoori S; Gopi S; Shaikh IA; Saif A; Bantun F; Faidah HS; Alhadi AA; Alshehri JH; Alharbi AA; S R PK; Joshi SD
PLoS One; 2024; 19(5):e0303173. PubMed ID: 38739587
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, molecular docking and 3D-QSAR studies of potent inhibitors of enoyl-acyl carrier protein reductase as potential antimycobacterial agents.
More UA; Joshi SD; Aminabhavi TM; Gadad AK; Nadagouda MN; Kulkarni VH
Eur J Med Chem; 2014 Jan; 71():199-218. PubMed ID: 24292339
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, evaluation and in silico molecular modeling of pyrroyl-1,3,4-thiadiazole inhibitors of InhA.
Joshi SD; More UA; Koli D; Kulkarni MS; Nadagouda MN; Aminabhavi TM
Bioorg Chem; 2015 Apr; 59():151-67. PubMed ID: 25800133
[TBL] [Abstract][Full Text] [Related]
10. FabI (enoyl acyl carrier protein reductase) - A potential broad spectrum therapeutic target and its inhibitors.
Rana P; Ghouse SM; Akunuri R; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2020 Dec; 208():112757. PubMed ID: 32883635
[TBL] [Abstract][Full Text] [Related]
11. A rational approach to identify inhibitors of Mycobacterium tuberculosis enoyl acyl carrier protein reductase.
Chhabria MT; Parmar KB; Brahmkshatriya PS
Curr Pharm Des; 2013; 19(21):3878-83. PubMed ID: 23477735
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a potent enoyl-acyl carrier protein reductase (FabI) inhibitor suitable for antistaphylococcal agent.
Kim YG; Seo JH; Kwak JH; Shin KJ
Bioorg Med Chem Lett; 2015 Oct; 25(20):4481-6. PubMed ID: 26343826
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of phaitanthrin congeners as anti-mycobacterial agents.
Kamal A; Reddy BV; Sridevi B; Ravikumar A; Venkateswarlu A; Sravanthi G; Sridevi JP; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2015 Sep; 25(18):3867-72. PubMed ID: 26253635
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
Doğan ŞD; Gündüz MG; Doğan H; Krishna VS; Lherbet C; Sriram D
Eur J Med Chem; 2020 Aug; 199():112402. PubMed ID: 32417538
[TBL] [Abstract][Full Text] [Related]
16. Identification of Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors: A combined in-silico and in-vitro analysis.
Lone MY; Athar M; Gupta VK; Jha PC
J Mol Graph Model; 2017 Sep; 76():172-180. PubMed ID: 28734205
[TBL] [Abstract][Full Text] [Related]
17. Crystallographic insights into the structure-activity relationships of diazaborine enoyl-ACP reductase inhibitors.
Jordan CA; Sandoval BA; Serobyan MV; Gilling DH; Groziak MP; Xu HH; Vey JL
Acta Crystallogr F Struct Biol Commun; 2015 Dec; 71(Pt 12):1521-30. PubMed ID: 26625295
[TBL] [Abstract][Full Text] [Related]
18. Methyl-branched fatty acids, inhibitors of enoyl-ACP reductase with antibacterial activity from Streptomyces sp. A251.
Zheng CJ; Sohn MJ; Chi SW; Kim WG
J Microbiol Biotechnol; 2010 May; 20(5):875-80. PubMed ID: 20519910
[TBL] [Abstract][Full Text] [Related]
19. Tryptanthrin Analogues as Inhibitors of Enoyl-acyl Carrier Protein Reductase: Activity against Mycobacterium tuberculosis, Toxicity, Modeling of Enzyme Binding.
Duca G; Pogrebnoi S; Boldescu V; Aksakal F; Uncu A; Valica V; Uncu L; Negres S; Nicolescu F; Macaev F
Curr Top Med Chem; 2019; 19(8):609-619. PubMed ID: 30834838
[TBL] [Abstract][Full Text] [Related]
20. Structural and biological evaluation of a novel series of benzimidazole inhibitors of Francisella tularensis enoyl-ACP reductase (FabI).
Mehboob S; Song J; Hevener KE; Su PC; Boci T; Brubaker L; Truong L; Mistry T; Deng J; Cook JL; Santarsiero BD; Ghosh AK; Johnson ME
Bioorg Med Chem Lett; 2015 Mar; 25(6):1292-6. PubMed ID: 25677657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
